Aim Bulletin

China weakness sees profits fall for Bioventix

By Josh White

Date: Monday 27 Oct 2025

(Sharecast News) - Bioventix reported lower annual profits on Monday, as weakness in its core markets, particularly China, offset gains from growing demand for its neurological diagnostic antibodies.
The AIM-traded company said profit before tax fell 5% to £10.1m for the year ended 30 June, while revenue declined 4% to £13.1m.

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page